ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The Diabetes Bloc-Stim Neuromodulation system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0 FLEX, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Código de la empresaRSLS
Nombre de la empresaReShape Lifesciences Inc
Fecha de salida a bolsaOct 06, 2016
Fundada en2008
Director ejecutivoMr. Paul F. Hickey
Número de empleados17
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 06
Dirección1001 Calle Amanecer
CiudadSAN CLEMENTE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal92673
Teléfono19494296680
Sitio Webhttps://www.reshapelifesciences.com/obalon/
Código de la empresaRSLS
Fecha de salida a bolsaOct 06, 2016
Fundada en2008
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos